FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Bracco Diagnostics Gastrografin Recall

Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organica…

Bracco Diagnostics Inc · Monroe Township, NJ

Risk level
Class II
Reported by FDA
Aug 21, 2013
Recall ID
D-885-2013
Check your lot numberHow we source this data

Summary

Bracco Diagnostics recalled Gastrografin starting Jun 21, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-885-2013 on Aug 21, 2013. Reason: Presence of foreign substance: One lot of the product may contain black foreign particles. Status: Terminated.

Why it was recalled

Presence of foreign substance: One lot of the product may contain black foreign particles

Product description

Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organically Bound Iodine, 120 ml bottle, Rx only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ 08543 by Therapex, Division of E-Z-EM Canada Inc. Anjou Quebec H1J2Z4, Canada, NDC 0270-0445-40

Lot numbers, UPCs & expiration codes

Lot # 00500512, Exp. 11/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-885-2013
Classification
Class II
Status
Terminated
Recall initiated
Jun 21, 2013
FDA report date
Aug 21, 2013
Quantity
29,436 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Bracco Diagnostics Inc

Original FDA data

Every field from FDA enforcement report D-885-2013, exactly as published.

Show all FDA fields
City
Monroe Township
State
NJ
Status
Terminated
Country
United States
Event ID
65878
Address
259 Prospect Plains Rd.
Address (line 2)
Building H
Code information
Lot # 00500512, Exp. 11/15
Postal code
08831
Report date
Aug 21, 2013
Product type
Drugs
Recall number
D-885-2013
Classification
Class II
Recalling firm
Bracco Diagnostics Inc
Product quantity
29,436 bottles
Termination date
Jan 23, 2015
Reason for recall
Presence of foreign substance: One lot of the product may contain black foreign particles
Voluntary / mandated
Voluntary: Firm initiated
Product description
Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organically Bound Iodine, 120 ml bottle, Rx only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ 08543 by Therapex, Division of E-Z-EM Canada Inc. Anjou Quebec H1J2Z4, Canada, NDC 0270-0445-40
Distribution pattern
Nationwide
Recall initiation date
Jun 21, 2013
Initial firm notification
Letter
Center classification date
Aug 12, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-885-2013, published Aug 21, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls